Addiction Medicine Certification Examination (ABPM) β Questions and Answers
Question 1: Which PDMP (Prescription Drug Monitoring Program) practice is considered a key safety intervention for patients receiving controlled substances for addiction?
- Checking PDMP at every controlled substance prescription (Correct answer)
- Checking PDMP quarterly regardless of visit frequency
- Checking PDMP only at initial visit
- Using PDMP only when law enforcement requests it
Correct answer: Checking PDMP at every controlled substance prescription
Checking the PDMP at every controlled substance prescription identifies concurrent prescriptions and reduces diversion risk.
Question 2: A clinician suspects a patient is diverting buprenorphine based on consistently low or absent buprenorphine on UDS. What is the recommended next step?
- Report the patient to the DEA without discussion
- Immediately discharge the patient from the practice
- Discuss findings non-judgmentally, assess barriers to adherence, and adjust the treatment plan accordingly (Correct answer)
- Increase the buprenorphine dose to ensure compliance
Correct answer: Discuss findings non-judgmentally, assess barriers to adherence, and adjust the treatment plan accordingly
Clinician-patient dialogue addressing barriers is the evidence-based first response before considering program changes.
Question 3: Which of the following lifestyle changes has the strongest evidence for enhancing neurobiological recovery and reducing relapse risk in substance use disorders?
- Vocational rehabilitation as the primary intervention
- Meditation alone without other behavioral interventions
- Regular aerobic exercise increasing BDNF and dopamine function (Correct answer)
- Dietary supplementation with omega-3 fatty acids
Correct answer: Regular aerobic exercise increasing BDNF and dopamine function
Aerobic exercise increases brain-derived neurotrophic factor (BDNF) and normalizes dopamine receptor density, supporting neurobiological recovery and reducing craving.
Question 4: When an addiction medicine specialist is asked to provide expert testimony in a legal case involving a patient they have treated, the most significant ethical concern is:
- Managing dual role conflict between treating clinician and expert witness (Correct answer)
- Ensuring testimony is favorable to the patient's legal position
- Charging a fair fee for expert services
- Obtaining DEA approval to discuss controlled substances in court
Correct answer: Managing dual role conflict between treating clinician and expert witness
Serving as both treating clinician and expert witness creates a dual role conflict that can compromise objectivity and harm the therapeutic relationship.
Question 5: Which of the following is a common relapse trigger?
- Regular exercise
- Stress (Correct answer)
- Support group meetings
- Healthy eating
Correct answer: Stress
Stress is a very common and powerful relapse trigger because it can overwhelm an individual's coping mechanisms and lead them to seek comfort or escape through substance use. Learning effective stress management techniques is a crucial component of relapse prevention, helping individuals navigate challenging situations without returning to old patterns of substance use.
Question 6: When developing a treatment plan for a patient with co-occurring PTSD and alcohol use disorder, which integrated approach is supported by evidence?
- Treat PTSD only after achieving 12 months of sobriety
- Treat alcohol use disorder first, then sequentially address PTSD
- Refer PTSD exclusively to mental health providers with no addiction medicine involvement
- Use simultaneous, integrated treatment addressing both disorders concurrently (Correct answer)
Correct answer: Use simultaneous, integrated treatment addressing both disorders concurrently
Integrated concurrent treatment of co-occurring PTSD and AUD (e.g., Seeking Safety, CPT with naltrexone) produces better outcomes than sequential approaches.
Question 7: Understanding the neurobiology of addiction has most directly informed which clinical approach?
- Confrontational counseling techniques aimed at breaking denial
- Medication-assisted treatment targeting specific neurobiological receptor systems disrupted by addiction (Correct answer)
- Abstinence-only treatment programs that discourage all medications
- Criminal justice deterrents using punishment to reduce substance use
Correct answer: Medication-assisted treatment targeting specific neurobiological receptor systems disrupted by addiction
Understanding specific neurobiological mechanisms has directly enabled development of targeted pharmacotherapies such as methadone, buprenorphine, and naltrexone that act on the same receptor systems affected by addictive substances.
Question 8: A patient with opioid use disorder declines buprenorphine but agrees to extended-release naltrexone. Which prerequisite must be met before initiating XR-naltrexone?
- Taper methadone to zero before the induction visit
- Enroll in a residential program for a minimum of 30 days
- Complete 7β10 days of opioid abstinence to avoid precipitated withdrawal (Correct answer)
- Obtain a liver biopsy to rule out hepatic fibrosis
Correct answer: Complete 7β10 days of opioid abstinence to avoid precipitated withdrawal
XR-naltrexone requires full opioid detoxification (typically 7β10 days abstinence) to prevent precipitated withdrawal.
Question 9: A patient on buprenorphine maintenance presents with severe chest pain, diaphoresis, and an irregular pulse. What is the FIRST priority?
- Discontinue buprenorphine and monitor
- Administer naloxone immediately
- Increase the buprenorphine dose to relieve pain
- Call 911 and initiate cardiac emergency protocols (Correct answer)
Correct answer: Call 911 and initiate cardiac emergency protocols
Chest pain with diaphoresis and irregular pulse suggests a cardiac emergency requiring immediate EMS activation and ACLS protocols.
Question 10: Acamprosate is thought to reduce alcohol cravings primarily by modulating which neurotransmitter system?
- Glutamate (NMDA) and GABA systems to restore balance (Correct answer)
- GABA-A receptor upregulation only
- Opioid receptor antagonism
- Dopaminergic reward pathways
Correct answer: Glutamate (NMDA) and GABA systems to restore balance
Acamprosate restores glutamateβGABA balance disrupted by chronic alcohol use, reducing the hyperexcitability and dysphoria that drive relapse.
Question 11: A patient in a methadone maintenance program asks to see their own treatment records. Under HIPAA, the program must provide access within:
- 10 days for SUD records only
- 7 business days
- 30 days, with one 30-day extension if needed (Correct answer)
- 60 days without exception
Correct answer: 30 days, with one 30-day extension if needed
HIPAA requires covered entities to provide patients access to their records within 30 days, with one 30-day extension allowed if written notice is given.
Question 12: Which brain region plays the most central role in drug craving and reward processing?
- Cerebellum
- Brain stem
- Spinal cord
- Nucleus accumbens (Correct answer)
Correct answer: Nucleus accumbens
The nucleus accumbens, part of the ventral striatum, is the primary target of dopamine from the VTA and is critically involved in reward processing, craving, and drug-seeking behavior.
Question 13: Which statement best reflects the ethical use of urine drug testing (UDT) in addiction medicine practice?
- UDT should be used as a clinical tool to guide treatment decisions, with results discussed transparently with patients (Correct answer)
- UDT is unnecessary when a patient has been compliant for more than six months
- UDT should be used primarily as a punitive tool to catch patients lying
- UDT results should be reported to employers routinely to ensure workplace safety
Correct answer: UDT should be used as a clinical tool to guide treatment decisions, with results discussed transparently with patients
UDT is a clinical, not punitive, tool and results should always be discussed with patients to inform collaborative treatment planning.
Question 14: A patient on buprenorphine for OUD undergoes elective surgery. Which perioperative pain management strategy is most appropriate?
- Switch to methadone 24 hours before surgery for better pain control
- Continue buprenorphine and supplement with multimodal analgesia including higher-dose full opioid agonists if needed (Correct answer)
- Use only NSAIDs and regional anesthesia; no opioids should be used with buprenorphine
- Discontinue buprenorphine 72 hours preoperatively and switch to full opioid agonists
Correct answer: Continue buprenorphine and supplement with multimodal analgesia including higher-dose full opioid agonists if needed
Current evidence and guidelines support continuing buprenorphine perioperatively and using multimodal analgesia; discontinuation risks relapse and full opioid agonist requirements are simply higher due to receptor occupancy.
Question 15: A patient in your addiction medicine practice discloses that they are a truck driver who has been using opioids without a prescription. What is the most ethically appropriate initial action?
- Prescribe a safer opioid to reduce harm while they continue driving
- Immediately report the patient to the DMV without further discussion
- Explore the safety implications with the patient and counsel them on the risks and legal obligations (Correct answer)
- Discharge the patient from your practice to avoid liability
Correct answer: Explore the safety implications with the patient and counsel them on the risks and legal obligations
The clinician should first explore the situation with the patient, balancing confidentiality with public safety duties and guiding the patient toward safe, legal behavior.
Question 16: Which pharmacological property of buprenorphine makes it effective at low doses for managing acute pain in opioid-naive patients but requires higher doses in opioid-dependent patients?
- Its very high affinity for mu-opioid receptors and slow dissociation rate (high receptor avidity) (Correct answer)
- Its selective activity at delta-opioid receptors which mediates analgesia
- Its weak binding to kappa receptors causing dysphoria at higher doses
- Its extensive first-pass metabolism that reduces bioavailability variably
Correct answer: Its very high affinity for mu-opioid receptors and slow dissociation rate (high receptor avidity)
Buprenorphine's extremely high mu-receptor affinity and slow dissociation mean it displaces other opioids and requires higher doses to achieve adequate receptor occupancy in tolerant patients.
Question 17: Which motivational interviewing technique is MOST appropriate early in treatment planning when a patient is ambivalent about change?
- Setting firm behavioral contracts with consequences for non-compliance
- Confronting denial directly to break resistance
- Providing an expert-driven list of consequences of continued use
- Exploring and reflecting the patient's own reasons for change (Correct answer)
Correct answer: Exploring and reflecting the patient's own reasons for change
Reflecting the patient's own ambivalence and eliciting their intrinsic reasons for change is the core of motivational interviewing and is most effective during pre-contemplation and contemplation stages.
Question 18: Which cognitive-behavioral therapy technique is specifically designed to help patients identify high-risk situations for relapse?
- Functional analysis (Correct answer)
- Aversion therapy
- Systematic desensitization
- Flooding
Correct answer: Functional analysis
Functional analysis identifies the antecedents, behaviors, and consequences that precede substance use, helping patients recognize high-risk situations.
Question 19: When documenting a patient's refusal of recommended treatment in addiction medicine, the clinician should record:
- A mandatory psychiatric hold order
- A referral to a different provider without further documentation
- The refusal, information provided about risks, and the patient's stated reasons (Correct answer)
- Only the refusal date and clinician signature
Correct answer: The refusal, information provided about risks, and the patient's stated reasons
Informed refusal documentation should capture what the patient refused, the risks communicated, and the patient's reasons to protect both patient and provider.
Question 20: Which of the following best describes the Low-Dose Induction (Bernese method) of buprenorphine initiation?
- Gradually increasing buprenorphine doses over several days while the patient continues to use full-agonist opioids, avoiding precipitated withdrawal (Correct answer)
- Initiating buprenorphine only after achieving 30 days of complete abstinence
- Administering naloxone first to ensure the patient is opioid-free before buprenorphine
- Starting buprenorphine at the full therapeutic dose on day one without any opioid-free period
Correct answer: Gradually increasing buprenorphine doses over several days while the patient continues to use full-agonist opioids, avoiding precipitated withdrawal
The Bernese (microdosing) induction allows buprenorphine to be started in very small escalating doses alongside continued opioid use, preventing precipitated withdrawal.
Question 21: In the MATRICS framework for opioid use disorder pharmacotherapy, which of the following is NOT an FDA-approved medication for OUD?
- Naltrexone
- Clonidine (Correct answer)
- Buprenorphine
- Methadone
Correct answer: Clonidine
Clonidine is not FDA-approved for OUD treatment; it is used off-label to manage opioid withdrawal symptoms such as anxiety, agitation, and autonomic hyperactivity.
Question 22: According to Marlatt's relapse prevention model, which factor is considered the most proximal trigger for relapse?
- Decreased self-efficacy
- Abstinence violation effect (Correct answer)
- High-risk situation
- Negative emotional state
Correct answer: Abstinence violation effect
The abstinence violation effect β guilt and cognitive dissonance after a lapse β is the most proximal factor leading from a lapse to full relapse in Marlatt's model.
Question 23: During a structured interview, a patient endorses using alcohol to 'relieve stress.' This most likely represents which concept in addiction evaluation?
- Positive reinforcement
- Physical dependence
- Negative reinforcement (Correct answer)
- Tolerance
Correct answer: Negative reinforcement
Using a substance to relieve negative states (stress, anxiety) is a textbook example of negative reinforcement, a key driver of substance use maintenance.
Question 24: Which AUDIT-C score threshold is commonly used to indicate hazardous drinking in men?
- 3 or more
- 6 or more
- 8 or more
- 4 or more (Correct answer)
Correct answer: 4 or more
An AUDIT-C score of 4 or more in men (3 or more in women) indicates hazardous or harmful alcohol use.
Question 25: Which technique used in 12-step facilitation therapy encourages the patient to accept that addiction is a disease beyond personal control?
- Behavioral activation
- Surrender and acceptance (Correct answer)
- Motivational enhancement
- Cognitive restructuring
Correct answer: Surrender and acceptance
12-step facilitation therapy encourages 'surrender and acceptance' β acknowledging powerlessness over the substance and embracing the disease model as the first step toward recovery.
Question 26: A patient with alcohol use disorder has a CIWA-Ar score of 18. Which treatment approach is most clinically appropriate?
- Prescribe disulfiram immediately to deter drinking
- Reassure the patient and schedule outpatient follow-up in one week
- Initiate symptom-triggered benzodiazepine therapy in a medically supervised setting (Correct answer)
- Administer oral naltrexone and discharge home
Correct answer: Initiate symptom-triggered benzodiazepine therapy in a medically supervised setting
A CIWA-Ar score of 15β20 indicates moderate-to-severe withdrawal requiring symptom-triggered benzodiazepines in a supervised setting.
Question 27: A patient with opioid use disorder who is stable on buprenorphine/naloxone undergoes an elective cholecystectomy. Which perioperative opioid management strategy is most consistent with current evidence?
- Continue buprenorphine through the perioperative period and use multimodal analgesia (Correct answer)
- Convert to oral morphine equivalents based on buprenorphine dose
- Discontinue buprenorphine 72 hours before surgery and use full agonist opioids
- Switch to methadone 2 weeks before surgery for better opioid flexibility
Correct answer: Continue buprenorphine through the perioperative period and use multimodal analgesia
Current evidence and guidelines support continuing buprenorphine perioperatively and supplementing with multimodal non-opioid analgesia, as discontinuation increases relapse risk without clear analgesic benefit.
Question 28: Which of the following best describes the concept of 'therapeutic privilege' in addiction medicine?
- Prescribing controlled substances for therapeutic purposes without DEA oversight
- A physician's authority to override a patient's refusal of treatment in emergencies
- The right of patients to choose their own treatment modality
- Withholding information from a patient on the grounds that disclosure would cause significant harm (Correct answer)
Correct answer: Withholding information from a patient on the grounds that disclosure would cause significant harm
Therapeutic privilege allows withholding information when its disclosure would cause serious harm, though it is rarely justified and is largely disfavored in modern ethics.
Question 29: What role do standard operating procedures play in Addiction Medicine Certification Pharmacology & Medication Management?
- Creating unnecessary paperwork
- Satisfying management only
- Ensuring consistency and quality through documented instructions (Correct answer)
- Restricting creativity
Correct answer: Ensuring consistency and quality through documented instructions
SOPs provide standardized instructions ensuring consistent quality regardless of which qualified person performs the work.
Question 30: Which neurotransmitter is primarily associated with the reward pathway in addiction?
- Dopamine (Correct answer)
- Serotonin
- Glutamate
- GABA
Correct answer: Dopamine
Dopamine is the primary neurotransmitter in the mesolimbic reward pathway and is central to the reinforcing effects of all major addictive substances.
Addiction Medicine Certification Examination (ABPM)
The ABPM Addiction Medicine Certification Examination tests physicians' competency across the full spectrum of addiction medicine, including neurobiology, pharmacology, clinical management of substance use disorders, prevention, and ethics. It is delivered in four one-hour blocks totaling 200 questions.
Exam Rules
- You can skip questions and return to them later
- Flag questions for review before submitting
- No feedback shown until you submit the entire exam
- Unanswered questions count as wrong β answer everything
- 10 pretest questions are mixed in and don't affect your score
- Timer auto-submits when time runs out
- Your progress is auto-saved every 30 seconds